Selenium for Ulcerative Colitis Patients on Biologics
Part of Digestive system clinical trials.
This trial tests whether taking selenium supplements can help people with moderate to severe ulcerative colitis that is being treated with advanced therapies (biologics). The goal is to see if selenium can improve symptoms and reduce inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate to severe ulcerative colitis.
- You are starting or switching to a biologic (like Remicade, Stelara, or Entyvio).
- You are between 18 and 85 years old.
- You are not pregnant or planning pregnancy during the study.
- You do not have kidney disease, diabetes, or thyroid problems.
- You are not taking blood thinners, certain antibiotics, or other drugs that may interact with selenium.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a probiotic supplement and trace elements to your current treatment helps manage mild to moderate ulcerative colitis. It aims to see if these additions can improve symptoms and quality of life.
This study tests an experimental tablet for people with moderate to severe ulcerative colitis that hasn't improved with standard treatments. It aims to see if the tablet can reduce symptoms and inflammation.
This trial tests a specially designed supplement that aims to restore healthy gut bacteria in people with mild-to-moderate ulcerative colitis. The goal is to reduce inflammation and improve symptoms like rectal bleeding and bowel urgency.
This study tests an investigational medication called LY4268989 for adults with moderate to severe ulcerative colitis (UC). It's for people who have tried other treatments without success. The goal is to see if the drug can reduce inflammation and improve symptoms.
This study tests an experimental drug called HSK47388 for people with moderate to severe ulcerative colitis who have not had good results from other treatments. The goal is to see if it can reduce inflammation and improve symptoms.
This study tests whether taking vitamin D3 by mouth can reduce inflammation in people with moderate ulcerative colitis and low vitamin D levels. It may help if you have a confirmed diagnosis and are between 20–40 years old.
Hear when a new Ulcerative Colitis (UC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.